Abstract
Purpose of Review
End-stage liver disease is associated with increased perioperative morbidity and mortality. This narrative review provides a summary of perioperative concerns and management of patients with end-stage liver disease.
Recent Findings
Model for end-stage liver disease (MELD) 3.0 is the most updated version of the MELD score which is used as both a prognostic score to prioritize organ allocation and to assess the severity of liver disease. The American Association for the Study of Liver Disease and The American Gastroenterological Association have provided updated guidelines on procedural bleeding and transfusion management in patients with liver disease. There is controversy on the issue of prophylactic transfusion for target thresholds prior to surgery.
Summary
Preoperative risk assessment is dependent on the severity of liver disease, type of surgery, urgency of surgery, age, and comorbidities. Patients with end-stage liver disease may need higher acuity of care in the postoperative period.
Similar content being viewed by others
Data Availability
No datasets were generated or analysed during the current study.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516–37. https://doi.org/10.1016/j.jhep.2023.03.017.
Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18(12):2650–66. https://doi.org/10.1016/j.cgh.2019.07.060.
National Vital Statistics Reports. Underlying cause of death, 2018-2021. National Center for Health Statistics 2021. https://www.cdc.gov/nchs/fastats/liver-disease.htm
Newman KL, Johnson KM, Cornia PB, Wu P, Itani K, Ioannou GN. Perioperative evaluation and management of patients with cirrhosis: risk assessment, surgical outcomes, and future directions. Clin Gastroenterol Hepatol. 2020;18(11):2398–414. https://doi.org/10.1016/j.cgh.2019.07.051.
Gilbert-Kawai N, Hogan B, Milan Z. Perioperative management of patients with liver disease. BJA Educ. 2022;22(3):111–7. https://doi.org/10.1016/j.bjae.2021.11.006.
Cheemerla S, Balakrishnan M. Global epidemiology of chronic liver disease. Clin Liver Dis. 2021;17(5):365–70. https://doi.org/10.1002/cld.1061.
. Mahmud N, Fricker Z, Serper M, Kaplan DE, Rothstein KD, Goldberg DS. In-hospital mortality varies by procedure type among cirrhosis surgery admissions. Liver Int. 2019;39(8):1394–9. https://doi.org/10.1111/liv.14156. Retrospective study reviewing in-hospital mortality and procedure type in patients with cirrhosis.
Northup PG, Friedman LS, Kamath PS. AGA clinical practice update on surgical risk assessment and perioperative management in cirrhosis: expert review. Clin Gastroenterol Hepatol. 2019;17(4):595–606. https://doi.org/10.1016/j.cgh.2018.09.043.
Mahmud N, Fricker Z, Hubbard RA, Ioannou GN, Lewis JD, Taddei TH, et al. Risk prediction models for post-operative mortality in patients with cirrhosis. Hepatology. 2021;73(1):204–18. https://doi.org/10.1002/hep.31558.
Pei KY, Asuzu DT, Davis KA. Laparoscopic colectomy reduces complications and hospital length of stay in colon cancer patients with liver disease and ascites. Surg Endosc. 2018;32(3):1286–92. https://doi.org/10.1007/s00464-017-5806-4.
Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus Statement. J Hepatol. 2020;73:202–9. https://doi.org/10.1016/j.jhep.2020.03.039.
Ayoub CH, Dakroub A, El-Asmar JM, Ali AH, Beaini H, Abdulfattah S, et al. Preoperative MELD score predicts mortality and adverse outcomes following radical cystectomy: analysis of American College of Surgeons National Surgical Quality Improvement Program. Ther Adv Urol. 2022;15(14):17562872221135944. https://doi.org/10.1177/17562872221135944.
Havens JM, Columbus AB, Olufajo OA, Askari R, Salim A, Christopher KB. Association of model for end-stage liver disease score with mortality in emergency general surgery patients. JAMA Surg. 2016;151(7):e160789. https://doi.org/10.1001/jamasurg.2016.0789.
•• Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, et al. MELD 3.0: the model for end-stage liver disease updated for the modern era. Gastroenterology. 2021;161(6):1887–1895.e4. https://doi.org/10.1053/j.gastro.2021.08.050. Update on the latest MELD.
Kalo E, George J, Read S, Majumdar A, Ahlenstiel G. Evolution of risk prediction models for post-operative mortality in patients with cirrhosis. Hepatol Int. 2023;17(3):542–5. https://doi.org/10.1007/s12072-023-10494-0.
•• O'Leary JG, Greenberg CS, Patton HM, Caldwell SH. AGA clinical practice update: coagulation in cirrhosis. Gastroenterology. 2019;157(1):34–43.e1. https://doi.org/10.1053/j.gastro.2019.03.070. Most recent American Gastroenterological Association Guidelines on cirrhosis.
•• Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;73(1):366–413. https://doi.org/10.1002/hep.31646. Updated guidelines from the American Association of Liver Disease (AASLD) on procedural bleeding in liver disease.
Manzano-Nunez R, Jimenez-Masip A, Chica-Yanten J, Ibn-Abdelouahab SM, de’ Angelis N, et al. Unlocking the potential of TIPS placement as a bridge to elective and emergency surgery in cirrhotic patients: a meta-analysis and future directions for endovascular resuscitation in acute care surgery. World J Emerg Surg. 2023;18(1):30. https://doi.org/10.1186/s13017-023-00498-4.
Wu Y, Zhu Y, Feng Y, Wang R, Yao N, Zhang M, et al. Royal free hospital-nutritional prioritizing tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with nutritional risk screening 2002. Br J Nutr. 2020;124(12):1293–302. https://doi.org/10.1017/S0007114520002366.
Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, et al. Frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(3):1611–44. https://doi.org/10.1002/hep.32049.
Markin N, Sharma A, Grant W, Shillcutt S. The safety of transesophageal echocardiography in patients undergoing orthotopic liver transplantation. J Cardiothorac Vasc Anesth. 2015;29(3):588–93. https://doi.org/10.1053/j.jvca.2014.10.012.
Canillas L, Pelegrina A, Álvarez J, Colominas-González E, Salar A, Aguilera L, Burdio F, Montes A, Grau S, Grande L, Carrión JA. Clinical guideline on perioperative management of patients with advanced chronic liver disease. Life (Basel). 2023;13(1):132. https://doi.org/10.3390/life13010132.
Simegn AE, Melesse DY, Bizuneh YB, Alemu WM. Perioperative management of patients with liver disease for non-hepatic surgery: a systematic review. Ann Med Surg (Lond). 2022;24(75):103397. https://doi.org/10.1016/j.amsu.2022.103397.
Deana C, Barbariol F, D’Incà S, et al. Sugammadex versus neostigmine after rocuronium continuous infusion in patients undergoing liver transplantation. BMC Anesthesiol. 2020;20(1):70. https://doi.org/10.1186/s12871-020-00986-z.
Fujita A, Ishibe N, Yoshihara T, Ohashi J, Makino H, Ikeda M, et al. Rapid reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients with liver dysfunction undergoing hepatic surgery. Acta Anaesthesiol Taiwan. 2014;52(2):54–8. https://doi.org/10.1016/j.aat.2014.04.007.
Rai R, Nagral S, Nagral A. Surgery in a patient with liver disease. J Clin Exp Hepatol. 2012;2(3):238–46. https://doi.org/10.1016/j.jceh.2012.05.003.
Van Limmen J, Wyffels P, Berrevoet F, Vanlander A, Coeman L, Wouters P, et al. Effects of propofol and sevoflurane on hepatic blood flow: a randomized controlled trial. BMC Anesthesiol. 2020;20(1):241. https://doi.org/10.1186/s12871-020-01150-3.
Brezeanu LN, Brezeanu RC, Diculescu M, Droc G. Anaesthesia for liver transplantation: an update. J Crit Care Med (Targu Mures). 2020;6(2):91–100. https://doi.org/10.2478/jccm-2020-0011.
Self WH, Semler MW, Wanderer JP, Wang L, Byrne DW, Collins SP, et al. Balanced crystalloids versus saline in noncritically ill adults. N Engl J Med. 2018;378:819–28. https://doi.org/10.1056/NEJMoa1711586.
Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651–3.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–60. https://doi.org/10.1016/j.jhep.2018.03.024.
Seshadri A, Appelbaum R, Carmichael SP 2nd, Cuschieri J, Hoth J, Kaups KL, et al. Management of decompensated cirrhosis in the surgical ICU: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document. Trauma Surg Acute Care Open. 2022;7(1):e000936. https://doi.org/10.1136/tsaco-2022-000936.
Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2017;65(1):310–35. https://doi.org/10.1002/hep.28906.
Liu P, Hum J, Jou J, Scanlan RM, Shatzel J. Transfusion strategies in patients with cirrhosis. Eur J Haematol. 2020;104(1):15–25. https://doi.org/10.1111/ejh.13342.
Rakoski M, Goyal P, Spencer-Safier M, Weissman J, Mohr G, Volk M. Pain management in patients with cirrhosis. Clin Liver Dis (Hoboken). 2018;11(6):135–40. https://doi.org/10.1002/cld.711.
Richter B, Schmandra TC, Golling M, Bechstein WO. Nutritional support after open liver resection: a systematic review. Dig Surg. 2006;23:139–45. https://doi.org/10.1159/000094345.
Bedewy A, El-Kassas M. Anesthesia in patients with chronic liver disease: an updated review. Clin Res Hepatol Gastroenterol. 2023;47(8):102205. https://doi.org/10.1016/j.clinre.2023.102205.
Joliat GR, Kobayashi K, Hasegawa K, Thomson JE, Padbury R, Scott M, et al. Guidelines for perioperative care for liver surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations 2022. World J Surg. 2023;47(1):11–34. https://doi.org/10.1007/s00268-022-06732-5.
Taylor N, Pierce ET. The patient with hepatic disease. In: Longnecker DE, Mackey SC, Newman MF, Sandberg WS, Zapol WM, editors. Anesthesiology, 3e. McGraw Hill; 2017. https://accessanesthesiology-mhmedical-com.foyer.swmed.edu/content.aspx?bookid=2152§ionid=164218164.
Lopez-Delgado JC, Ballus J, Esteve F, et al. Outcomes of abdominal surgery in patients with liver cirrhosis. World J Gastroenterol. 2016;22(9):2657–67. https://doi.org/10.3748/wjg.v22.i9.2657.
Author information
Authors and Affiliations
Contributions
F.S. - created the outline and guidelines for the paper- wrote the abstract, preoperative management section, and conclusion- designed the tables- critically revised all sections of the paper. A.O. - wrote the initial drafts of the intraoperative management section. T.R. - wrote the initial drafts of the introduction and postoperative management sections.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Simmons, F., Roberson, T. & Owolabi, A. Perioperative Management of the Patient with End-Stage Liver Disease. Curr Anesthesiol Rep (2024). https://doi.org/10.1007/s40140-024-00618-z
Accepted:
Published:
DOI: https://doi.org/10.1007/s40140-024-00618-z